.jpg "Ann R. Falsey, MD photo")
Dr
University of Rochester School of Medicine
Disclosure(s): ADMA: Board Member; BioFire Diagnostics: Grant/Research Support; CyanVac: Grant/Research Support; GSK: Advisor/Consultant, Travel support; Janssen: Grant/Research Support; Moderna: Advisor/Consultant, Grant/Research Support; Pfizer: Advisor/Consultant, Grant/Research Support; Sanofi Pasteur: Advisor/Consultant, Travel support; VaxCo: Grant/Research Support
Dr Falsey is a Professor of Medicine at the University of Rochester School of Medicine. The focus of her research has been clinical and translational research in the field of respiratory viral infections in adults. Dr Falsey received her Bachelor of Science degree in Biology at Providence College and Doctorate in Medicine at Vanderbilt University School of Medicine. She completed her residency in Internal Medicine at Strong Memorial Hospital at the University of Rochester and infectious disease fellowship at Yale University and the University of Rochester. Initially the focus of her research was defining the epidemiology and impact of respiratory syncytial virus in adult populations. More recently, Dr Falsey has broadened her research to include numerous viral respiratory pathogens including influenza, coronaviruses, parainfluenza viruses and human metapneumovirus. She has conducted numerous adult surveillance and vaccine studies in a variety of settings including ambulatory older adult clinics, nursing homes and senior daycare centers. She has extensive experience in the development and performance of diagnostic and serologic assays for influenza and other respiratory viruses including cell culture, RT-PCR, EIA and neutralization assays. She is presently the Co-PI of the Rochester Vaccine Treatment and Evaluation Unit and conducts vaccine and therapeutic studies against SARS CoV-2.